Pharmafile Logo

Peter Impey

Bayer symbol

Bayer CEO Dekkers points to ‘outstanding’ pharma growth

On target to meet company’s annual expectations of €7.5bn

- PMLiVE

Boehringer and Lilly to restructure diabetes alliance

Say revisions to the alliance will not affect the world's largest markets

- PMLiVE

Pfizer gets FDA nod for meningitis vaccine Trumenba

Ahead of Novartis’ rival drug Bexsero

- PMLiVE

AZ to work with UK university on drug delivery technologies

Company's staff will also teach parts of courses at The University of Manchester

- PMLiVE

Farmaindustria names Antoni Esteve as president

Will hold the position for the next two years

GlobalData makes Americas appointment

Sean Hu has 18 years experience in life sciences consulting

- PMLiVE

Guidance is no barrier to engaging on Twitter

Five simple, compliant tactics for European pharma marketers to consider

- PMLiVE

Sanofi board votes out CEO Viehbacher

Unanimous decision ends weeks of speculation

- PMLiVE

117,000 hepatitis C patients receive Sovaldi so far

Breakthrough drug has made $8.5bn for Gilead this year

Bristol-Myers Squibb (BMS) building

BMS taps F-star Alpha for immuno-oncology drug

Drug in development for breast and stomach cancers

- PMLiVE

Karus names two division heads

Simon Roitt and Peter Finan strengthen research team

- PMLiVE

US judge cuts billions from Takeda/Lilly Actos payment

Court rules that companies must now pay damages of $36.8m rather than $9bn

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links